Evid Invest
Holders — by stockHoldings — by fund

Tri Locum Partners LP

Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001826434

$506.1M

disclosed book value

18

positions

13.7%

largest position share

Positions, as of 2026-09-30

top 18 of 18 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held

#IssuerSharesValue% of book
1VRTXVERTEX PHARMACEUTICALS INC132,896$69.5M13.7%
2LLYELI LILLY & CO51,015$59.0M11.7%
3TEVATEVA PHARMACEUTICAL INDS LTD1.2M$48.5M9.6%
4AMRXAMNEAL PHARMACEUTICALS INC2.3M$46.9M9.3%
5DXCMDEXCOM INC489,400$42.2M8.3%
6JAZZJAZZ PHARMACEUTICALS PLC160,321$37.1M7.3%
7ARGXARGENX SE30,399$29.1M5.8%
8ASNDASCENDIS PHARMA A/S118,384$27.0M5.3%
9AXSMAXSOME THERAPEUTICS INC.143,338$26.4M5.2%
10JNJJOHNSON & JOHNSON73,559$19.5M3.8%
11ELVNENLIVEN THERAPEUTICS INC410,236$18.8M3.7%
12UTHRUNITED THERAPEUTICS CORP DEL33,000$17.9M3.5%
13MDGLMADRIGAL PHARMACEUTICALS INC33,668$17.0M3.4%
14CELCCELCUITY INC202,618$16.1M3.2%
15DNTHDIANTHUS THERAPEUTICS INC177,225$15.6M3.1%
16RVMDREVOLUTION MEDICINES INC40,019$8.2M1.6%
17DFTXDEFINIUM THERAPEUTICS INC144,406$5.5M1.1%
18VRDNVIRIDIAN THERAPEUTICS INC90,107$1.9M0.4%

Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.